---
search:
  boost: 3
---

# Anticonvulsants

This is a subcategory of Central Nervous System (CNS) Agents.

## Decision Trees

- [CNS - Anticonvulsants - Non-Preferred](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUNlNZRUM3NE1RM080QlQ2NzYwNzM4Q1RHNiQlQCN0PWcu){ :target="_blank" rel="noopener"}
- [CNS - Anticonvulsants - Diacomit](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUNE5PUzJSVTdKWUpIVDk3TjJMSlVIQlJKMiQlQCN0PWcu){ :target="_blank" rel="noopener"}
- [CNS - Anticonvulsants - Epidiolex](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUQUs4U0FEMU1LRldKV1dGMExUOEw5QjNXWCQlQCN0PWcu){ :target="_blank" rel="noopener"}
- [CNS - Anticonvulsants - Eprontia](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBURFAxTkE0VzNYUkpEMURaRkVNMlk5T1lVQyQlQCN0PWcu){ :target="_blank" rel="noopener"}
- [CNS - Anticonvulsants - Fycompa, Lacosamide](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUM1AyWk82M1JKVlFJUlo0SzJHMUxKR0lJOSQlQCNjPTEkJUAjdD1n){ :target="_blank" rel="noopener"}
- [CNS - Anticonvulsants - Vigabatrin Powder](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUNDFNR1ZWWTgyT0lYMVdPUlA4UjdGWlpDWSQlQCN0PWcu){ :target="_blank" rel="noopener"}

## Formulary

### Preferred

| Preferred                          | Generic Name                                        |         Quantity          |        Time (Days)        |
|:-----------------------------------|:----------------------------------------------------|:-------------------------:|:-------------------------:|
| Banzel Tab <sup>BvG ==(Process by NDC)==</sup>          |                                                     |                           |                           |
| Carbamazepine                      |                                                     |                           |                           |
| Clobazam                           |                                                     |                           |                           |
| Clonazepam                         |                                                     |                           |                           |
| Diacomit <sup>PA QL</sup>          | Stiripentol Cap/Pack (all strengths)                | Determined pursuant to PA | Determined pursuant to PA |
| Divalproex IR                      |                                                     |                           |                           |
| Divalproex ER                      |                                                     |                           |                           |
| Epidiolex <sup>ST QL</sup>         | Cannabidiol Soln (all strengths)                    | Determined pursuant to PA | Determined pursuant to PA |
| Eprontia <sup>AR</sup>             |                                                     |                           |                           |
| Ethosuximide                       |                                                     |                           |                           |
| Fycompa <sup>ST</sup>              |                                                     |                           |                           |
| Gabapentin <sup>QL</sup>           | Gabapentin Cap / Tab 100 MG                         |            204            |            34             |
| Gabapentin <sup>QL</sup>           | Gabapentin Cap / Tab 300 MG                         |            408            |            34             |
| Gabapentin <sup>QL</sup>           | Gabapentin Cap / Tab 400 MG                         |            306            |            34             |
| Gabapentin <sup>QL</sup>           | Gabapentin Tab 600 MG                               |            204            |            34             |
| Gabapentin <sup>QL</sup>           | Gabapentin Tab 800 MG                               |            136            |            34             |
| Gabapentin Soln <sup>QL</sup>      | Gabapentin Oral Soln 250 MG / 5 ML                  |           2448            |            34             |
| Lacosamide <sup>ST</sup>           |                                                     |                           |                           |
| Lacosamide Soln <sup>ST</sup>      | Lacosamide Oral Solution (all strengths)            | Determined pursuant to PA | Determined pursuant to PA |
| Lamotrigine                        |                                                     |                           |                           |
| Lamotrigine IR, ODT                |                                                     |                           |                           |
| Levetiracetam IR Tab               |                                                     |                           |                           |
| Levetiracetam Sol                  |                                                     |                           |                           |
| Oxcarbazepine Tab                  |                                                     |                           |                           |
| Phenobarbital                      |                                                     |                           |                           |
| Phenytoin                          |                                                     |                           |                           |
| Pregabalin <sup>QL</sup>           | Pregabalin Cap (all strengths excl 225 MG & 300 MG) |            102            |            34             |
| Pregabalin <sup>QL</sup>           | Pregabalin Cap 225 MG & 300 MG                      |            68             |            34             |
| Primidone                          |                                                     |                           |                           |
| Topiramate                         |                                                     |                           |                           |
| Trileptal Susp <sup>BvG ==(Process by NDC)==</sup>      |                                                     |                           |                           |
| Valproic Acid                      |                                                     |                           |                           |
| Zonisamide                         |                                                     |                           |                           |

### Non-Preferred

| Non-Preferred                                                                                        | Generic Name | Quantity | Time (Days) |
|:-----------------------------------------------------------------------------------------------------|:-------------|:--------:|:-----------:|
| Aptiom                                                                                               |              |          |             |
| Briviact                                                                                             |              |          |             |
| Celontin                                                                                             |              |          |             |
| Clonazepam ODT                                                                                       |              |          |             |
| Elepsia XR                                                                                           |              |          |             |
| Felbamate                                                                                            |              |          |             |
| Fintepla                                                                                             |              |          |             |
| Lamotrigine ER                                                                                       |              |          |             |
| Levetiracetam ER Tab                                                                                 |              |          |             |
| <span title = "Brand Preferred: Trileptal Susp">Oxcarbazepine Susp</span> <sup>Brand Preferred</sup> |              |          |             |
| Oxtellar XR                                                                                          |              |          |             |
| Peganone                                                                                             |              |          |             |
| Qudexy XR <sup>BvG ==(Process by NDC)==</sup>                                                                             |              |          |             |
| <span title = "Brand Pre ferred: Banzel Tab">Rufinamide Tab, Soln</span> <sup>Brand Preferred Tab only</sup>  |              |          |             |
| Spritam                                                                                              |              |          |             |
| Sympazan                                                                                             |              |          |             |
| Tiagabine                                                                                            |              |          |             |
| Topiramate Sprinkle Cap                                                                              |              |          |             |
| Trokendi XR <sup>BvG ==(Process by NDC)==</sup>                                                                           |              |          |             |
| Vigabatrin                                                                                           |              |          |             |
| Vigabatrin Powder <sup>AR</sup>                                                                      |              |          |             |
| Xcopri                                                                                               |              |          |             |
| Zonisade Susp                                                                                        |              |          |             |
| Ztalmy                                                                                               |              |          |             |

## Authorizations

**Length of Authorizations**: 365 Days except Epidiolex and Diacomit - Initial: 180 days

### Grandfathering* (except Diacomit)

Patients who have a claim for a non-preferred drug in the previous 120 days will be automatically approved to continue the drug. Patients who have taken the drug previously, but do not have claims history (e.g. new to Medicaid), will need to submit a prior authorization in order to continue coverage.

**All Authorizations**: Must be prescribed in accordance with FDA approved labeling

## Criteria

### Step Therapy

Step Therapy Approval Criteria

- Must have had an inadequate clinical response of at least ^^30 days^^ with at least ^^one
preferred^^ drug
 
### Cannabidiol (Epidiolex)

Cannabidiol (Epidiolex) Criteria

- Must have had an inadequate clinical response of at least ^^30 days^^ with any ^^two^^ of the following anticonvulsants: clobazam, levetiracetam, valproic acid, lamotrigine, topiramate, rufinamide, or felbamate within the past ^^365 days^^ (members who meet this criteria will not require a PA)

### Stiripentol (Diacomit)

Stiripentol (Diacomit) Criteria

- Must be prescribed by or in consultation with a neurologist
- Must be concomitantly taking clobazam (Onfi)
- Must provide documentation of addressed comorbidities and baseline hematologic testing (CBC)
    - Patients with phenylketonuria (PKU) must provide evidence of total daily amount of phenylalanine
    - Prescribers must include management plans for patients with neutrophil counts <1,500 cells/mm3 or platelet count <150,000/µL
- Must provide documentation of patient’s weight
    - Maximum daily dose does not exceed: 50 mg/kg/day or 3,000 mg/day
- Must provide baseline average number of seizure days per month (measured monthly or quarterly)

### Non-Preferred 

Non-Preferred Criteria

- Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    - For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
- Must have had an inadequate clinical response of at least ^^30 days^^ with at least ^^two preferred^^ drugs
    - For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    - For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)
- Prescriptions submitted from a prescriber who is registered as a ***neurology specialty*** with Ohio Medicaid AND for drugs that are used only for seizures, there must have been an ***inadequate clinical response of ^^at least 30 days with one preferred^^ drug***. This provision applies only to the standard tablet/capsule dosage form and does not apply to brand products with available generic alternatives.

[**Onfi (Clobazam) DAW Guidance](https://special-spoon-f542dccd.pages.github.io/Pharmacist%20Reference%20Guide/Medication%20Guidance/onfi/?h=onfi)

### Subsequent Authorization

Subsequent Authorization Criteria

- Must provide documentation of patient's clinical response to treatment and ongoing safety monitoring (i.e., documented reduction in average number of seizure days per month [measured monthly or quarterly])

**AR** - Vigabatrin Powder: a PA is required for patients 3 years and older </br>
**AR** - Eprontia Solution: a PA is required for patients 12 years and older

## Links

[Denial Language (Rph Use Only: Technicians CANNOT deny Prior Authorizations)](https://mygainwell-my.sharepoint.com/:w:/g/personal/rachel_carpenter_gainwelltechnologies_com/EWN_d80YfxNHjWqwQ77mMfUB4JILmO6MEqvBSxlBn5-uug?e=mdkuXX23&cid=f4472ece-6d4f-4694-b0c5-c150a2f53fea){:target="_blank" rel="noopener"}

[Criteria](https://medicaid.ohio.gov/static/PHM/drug-coverage/20230701+UPDL+Criteria+_v1_FINAL.approved.pdf#page=30){ :target="_blank" rel="noopener"} </br>
[Preferred Drug List](https://medicaid.ohio.gov/static/PHM/drug-coverage/20230701_UPDL_FINAL_ODM.approved.v2.pdf#page=14){ :target="_blank" rel="noopener"} </br>
[Quantity Limit List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf){ :target="_blank" rel="noopener"}
